Margaret C. Wu is a Chinese-American biostatistician who worked at the National Heart, Lung, and Blood Institute on topics including the analysis of clinical trials, longitudinal studies, and censored data. [1]
Wu earned a Ph.D. in 1973 from Johns Hopkins University, with the dissertation Asymptotic Behavior of Posterior Distributions and Bayes's Estimators for the Independent Not Identically Distributed Case, supervised by Charles A. Rohde. [2]
She worked in the Office of Biostatistics Research at the National Heart, Lung, and Blood Institute, part of the National Institutes of Health (NIH), from 1973 until her retirement in 2001. [1]
Wu won the National Institutes of Health MERIT Award in 1989. [3] She was elected as a Fellow of the American Statistical Association in 1994. [4]
The National Heart, Lung, and Blood Institute (NHLBI) is the third largest Institute of the National Institutes of Health, located in Bethesda, Maryland, United States. It is tasked with allocating about $3.6 billion in FY 2020 in tax revenue to advancing the understanding of the following issues: development and progression of disease, diagnosis of disease, treatment of disease, disease prevention, reduction of health care disparities within the American population, and advancing the effectiveness of the US medical system. NHLBI's Director is Gary H. Gibbons (2012–present).
Bernadine Patricia Healy was an American cardiologist and the first female director of the National Institutes of Health (NIH).
Dr. Margaret Jane Pittman (1901–1995) was a pioneering bacteriologist whose research at the National Institutes of Health (NIH) on typhoid, cholera, and pertussis helped generate the development of vaccinations against these diseases as well as others. Dr. Pittman was also the first female to lead a NIH laboratory, when in 1957, she was appointed chief of their Laboratory of Bacterial Products, a position she held until 1971. In the 1960s she was a key NIH participant in developing standards for cholera vaccine in the Southeast Asia Treaty Organization's campaign to control cholera in the region that is now Bangladesh. After her retirement in 1971, she continued to work for the World Health Organization as a consultant on vaccine standards, working in Cairo and Madrid and for the State Institute for Serum and Vaccine in Iran and Connaught Laboratories, Ltd., in Toronto.
Harvey James Alter is an American medical researcher, virologist, physician and Nobel Prize laureate, who is best known for his work that led to the discovery of the hepatitis C virus. Alter is the former chief of the infectious disease section and the associate director for research of the Department of Transfusion Medicine at the Warren Grant Magnuson Clinical Center in the National Institutes of Health (NIH) in Bethesda, Maryland. In the mid-1970s, Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A or hepatitis B viruses. Working independently, Alter and Edward Tabor, a scientist at the U.S. Food and Drug Administration, proved through transmission studies in chimpanzees that a new form of hepatitis, initially called "non-A, non-B hepatitis" caused the infections, and that the causative agent was probably a virus. This work eventually led to the discovery of the hepatitis C virus in 1988, for which he shared the Nobel Prize in Physiology or Medicine in 2020 along with Michael Houghton and Charles M. Rice.
Elizabeth Nabel is an American cardiologist and the current Executive Vice President of Strategy at ModeX Therapeutics in Natick, Massachusetts. Prior to this role, she served as President of Brigham Health and its Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School, and Director of the NIH's National Heart, Lung, and Blood Institute.
Marianne J. Legato, MD, PhD, FACP, is an internationally-known academic physician, author, and lecturer and globally recognized expert in gender-specific medicine, the science of how normal human function and the experience of the same disease vary as a function of gender/biological sex.
Noreen M. Clark was the Myron E. Wegman Distinguished University Professor, Director of the Center for Managing Chronic Disease, Professor of Health Behavior & Health Education, and Professor of Pediatrics at the University of Michigan. From 1995-2005 she served as Dean of Public Health and Marshall H. Becker Professor of Public Health at the University of Michigan. She was interested in systems, policies and programs that promote health, prevent illness, and enable individuals to manage disease.
Kathryn Dorothy Duncan Anderson is a British-American pediatric surgeon. She was the first woman to hold office in the American College of Surgeons and the first woman president of the American Pediatric Surgical Association. She was a Nina Starr Braunwald Award laureate.
Margaret E. Martin was an economist and statistician at the U.S. Bureau of the Budget from 1942 to 1973. She was influential in the development of U.S. economic statistics and became president of the American Statistical Association.
Dr. Hannah Valantine is the Chief Officer for Scientific Workforce Diversity at the United States National Institutes of Health.
Clarice D. Reid is an American pediatrician born in Birmingham, Alabama, who led the National Sickle Cell Disease Program at the U.S. National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health. She went on to become the Director of Division of Blood Diseases and Resources at NHLBI. Reid was a member of the 1985-1986 Taskforce on Black and Minority Health. She has also served as President Emeritus on the American Bridge Association's Education and Charitable Foundation, and has scored a rare perfect bridge score.
Martha Vaughan was an American biochemist at the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) in Bethesda, Maryland. She holds the title of emeritus scientist in the Laboratory of Metabolic Regulation and previously served as chief of NHLBI’s Laboratory of Cellular Metabolism. At the NIH, much of her work has focused on cell signaling, cellular regulation, lipid metabolism, and the identification of key proteins associated with cholera toxin and pertussis toxin. Vaughan first came to the NIH in the agency’s fledgling National Heart Institute, now NHLBI, and with the title of senior assistant surgeon worked on protein synthesis in the Building 3 laboratory of biochemist and public scientist Christian B. Anfinsen, Ph.D., who went on to share the 1972 Nobel Prize in Chemistry
Clare M. Waterman is a cell biologist who has worked on understanding the role of the cytoskeleton in cell migration. Waterman is a Distinguished Investigator, Chief of the Laboratory of Cell and Tissue Morphodynamics, and Director of the Cell Biology and Physiology Center at the National Heart, Lung, and Blood Institute (NHLBI), in the National Institutes of Health (NIH) in Bethesda MD, USA. Waterman has received several awards and honors, including the Sackler International prize in Biophysics, the NIH Director’s Pioneer Award, and the Arthur S. Flemming Award for Public Service. In 2018, she was elected to the National Academy of Sciences. She currently serves on the editorial boards of eLife, Current Biology and Journal of Microscopy.
Phyllis C. Zee is the Benjamin and Virginia T. Boshes Professor in Neurology, the director of the Center for Circadian and Sleep Medicine (CCSM) and the chief of the Division of Sleep Medicine (neurology) at the Feinberg School of Medicine, Northwestern University, Chicago. She is also the medical director of Sleep Disorders Center at Northwestern Memorial Hospital.
Marilyn Nancy Lorch Geller is an American biostatistician, the director of biostatistics research at the National Heart, Lung, and Blood Institute and a former president of the American Statistical Association.
Harriet Pearson Dustan (1920–1999) was an American physician who is known for her pioneering contributions to effective detection and treatment of hypertension. She was the first woman to serve on the Board of Governors of the American Board of Internal Medicine.
Daniel Levy is a cardiologist who is the director of the Framingham Heart Study at the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health (NIH). He is also Professor of Medicine at Boston University School of Medicine. He is known for his research on the epidemiology and genetics of heart failure and hypertension.
James M. Anderson is an American Professor of Medicine and Cell Biology and is a Chief of Section of Digestive Diseases at the Yale School of Medicine. Anderson is also a director of the Division of Program Coordination, Planning, and Strategic Initiatives at the National Institutes of Health.
Xifeng Wu is a Chinese-American cancer epidemiologist known for her cohort studies designed to discover the causes of cancer. She has been Dean of the School of Public Health of Zhejiang University since March 2019. She previously served as Director of the Center for Public Health and Translational Genomics and the Betty B. Marcus Chair in Cancer Prevention at the University of Texas MD Anderson Cancer Center until she was forced to resign in January 2019, as part of the Trump administration's push to counter Chinese influence in American research according to Bloomberg Businessweek.
Swee Lay Thein is a Malaysian haematologist and physician-scientist who is Senior Investigator at the National Institutes of Health. She works on the pathophysiology of haemoglobin disorders including sickle cell disease and thalassemia.